Lee E, Walker C, Ayadi B Safety of Intravenous Infusion of BPC157 in Humans: A Pilot Study
Protocol overview: BPC-157 administered via subcutaneous injection, locally near the affected joint Standard dosing range: 200500 mcg per injection session Treatment duration: 48 weeks of active treatment Follow-up assessments: 6 months and 12 months post-treatment Patients were evaluated using validated pain scales (VAS and KOOS scores) and functional mobility assessments at each follow-up point
Long Journal of the American Chemical Society 1960 82 (4), 795-798 DOI : 10.1021/ja01489a008 This is the paper giving the pK a of water as 15.7 whose methods are criticized in the above articles
Multiple systematic reviews show improvement in pain and function scores compared to hyaluronic acid and placebo injections
cognitive responses vary, and any plan is adjusted to how your body responds
Read the draw volume (mL) first, then use the units display as a convenience